Gerber, Tiemo S.; Ridder, Dirk A.; Goeppert, Benjamin et al.
N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomasINTERNATIONAL JOURNAL OF CANCER. Bd. 154. H. 10. 2024 S. 1857-1868
Shitara, Kohei; Bang, Yung-Jue; Wyrwicz, Lucjan S. et al.
Neoadjuvant/adjuvant pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo for gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: Major pathologic response (mPR) in KEYNOTE-585JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024
Huber, Yvonne; Huber, Tobias; Reichermeier, Stefanie et al.
NEXT GEN at Visceral Medicine 2024: A ReviewZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 62. H. 11. 2024 S. 1981-1982
Moehler, Markus; Janjigian, Yelena Y.; Shitara, Kohei et al.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMateONCOLOGY RESEARCH AND TREATMENT. Bd. 47. 2024 S. 64-64
Shitara, Kohei; Moehler, Markus H.; Ajani, Jaffer A. et al.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4 year (yr) follow-up of CheckMate 649.JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 3_SUPPL. 2024 S. 306-306
Elimova, Elena; Shitara, Kohei; Moehler, Markus H. et al.
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4-year follow-up of CheckMate 649JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024
Galle, Peter Robert; Decaens, Thomas; Kudo, Masatoshi et al.
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW.JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 17_SUPPL. 2024 S. LBA4008-LBA4008
Hahad, Omar; Gilan, Donya; Michal, Matthias et al.
Noise annoyance and cardiovascular disease risk: results from a 10-year follow-up studySCIENTIFIC REPORTS. Bd. 14. H. 1. 2024
Michel, Maurice; Doll, Michelle; Albert, Nastasia et al.
Obesity and harmful alcohol consumption are predictors for advanced liver disease in the disease management program for type 2 diabetesUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. Bd. 12. H. 1. 2024 S. 11-21
Gottwald-Hostalek, Ulrike; Kahaly, George J.
Optimizing levothyroxine treatment for subclinical hypothyroidism during pregnancyCURRENT MEDICAL RESEARCH AND OPINION. Bd. 40. H. 1. 2024 S. 43-49